American Journal of Ophthalmology
Volume 139, Issue 1 , Pages 72-77 , January 2005

Interleukin-1β tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers

  • Gianluca Manni, MD

      Affiliations

    • University of Rome “Tor Vergata”, Dipartimento di Biopatologie e Diagnostica per Immagini; Fondazione G.B. Bietti for the Study and Research in Ophthalmology, Rome, Italy.
    • ,
  • Marco Centofanti, MD, PhD

      Affiliations

    • University of Rome “Tor Vergata”, Dipartimento di Biopatologie e Diagnostica per Immagini; Fondazione G.B. Bietti for the Study and Research in Ophthalmology, Rome, Italy.
    • ,
  • Francesco Oddone, MD

      Affiliations

    • University of Rome “Tor Vergata”, Dipartimento di Biopatologie e Diagnostica per Immagini; Fondazione G.B. Bietti for the Study and Research in Ophthalmology, Rome, Italy.
    • Corresponding Author InformationInquiries to Francesco Oddone, MD, Fondazione G.B. Bietti, Viale Oxford 81, Rome 00133, Italy
    • ,
  • Mariacristina Parravano, MD

      Affiliations

    • University of Rome “Tor Vergata”, Dipartimento di Biopatologie e Diagnostica per Immagini; Fondazione G.B. Bietti for the Study and Research in Ophthalmology, Rome, Italy.
    • ,
  • Massimo G. Bucci, MD

      Affiliations

    • University of Rome “Tor Vergata”, Dipartimento di Biopatologie e Diagnostica per Immagini; Fondazione G.B. Bietti for the Study and Research in Ophthalmology, Rome, Italy.

,Accepted 16 August 2004.

References 

  1. Lichter PR . Expectations from clinical trials. Results of the Early Manifest Glaucoma Trial . Arch Ophthalmol . 2002;120:1371–1372
  2. Gordon MO , Beiser JA , Brandt JD , et al.   The Ocular Hypertension Treatment Study (a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma) . Arch Ophthalmol . 2002;120:701–713
  3. Heijl A , Leske MC , Bengtsson B , et al.  Early Manifest Glaucoma Trial Group   Reduction of intraocular pressure and glaucoma progression (results from the Early Manifest Glaucoma Trial) . Arch Ophthalmol . 2002;120:1268–1279
  4. Collaborative Normal Tension Glaucoma Study Group . Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures . Am J Ophthalmol . 1998;126:487–497
  5. The AGIS Investigators . The Advanced Glaucoma Intervention Study (AGIS), VII (the relationship between control of intraocular pressure and visual field deterioration) . Am J Ophthalmol . 2000;130:429–440
  6. Lama PJ . Systemic adverse effects of beta-adrenergic blockers (an evidence-based assessment) . Am J Ophthalmol . 2002;134:749–760
  7. De Jong C , Solwijk T , Kuppens E , et al.   Topical timolol with and without benzalkonium chloride; epithelial permeability and autofluorescence of the cornea in glaucoma . Graefes Arch Clin Exp Ophthalmol . 1994;232:221–224
  8. Mietz H , Niesen U , Krielstein GK . The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva . Graefes Arch Clin Exp Ophthalmol . 1994;232:561–565
  9. Pisella PJ , Fillacier K , Elena P , et al.   Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbit . Ophthalmol Res . 2000;32:3–8
  10. Pisella PJ , Pouliquen P , Baudouin C . Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication . Br J Ophthalmol . 2002;86:418–423
  11. Wilson FM . Adverse external ocular effects of topical ophthalmic medications . Surv Ophthalmol . 1979;24:57–88
  12. Baudouin C , Garcher C , Haouat N , et al.   Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma . Ophthalmology . 1994;101:454–460
  13. Li DQ , Tseng SC . Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface . J Cella Physiol . 1995;163:61–79
  14. Becker J , Salla S , Dohmen U , et al.   Explorative study of interleukin levels in the human cornea . Graefes Arch Clin Exp Ophthalmol . 1995;233:766–771
  15. Taylor PC . Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases . Mol Biotechnol . 2001;19:153–168
  16. Sfikakis PP . Behcet’s disease (a new target for anti-tumor necrosis factor treatment [review]) . Ann Rheum Dis . 2002;61(suppl 2):ii51–ii53
  17. Arend WP . The mode of action of cytokine inhibitors [review] . J Rheumatol Suppl . 2002;65:16–21
  18. Bron AJ , Evans VE , Smith JA . Grading of corneal and conjunctival staining in the context of other dry eye tests . Cornea . 2003;22:640–649
  19. Pisella PJ , Debbasch C , Hamard P , et al.   Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol (an ex vivo and in vitro study) . Invest Ophthalmol Vis Sci . 2004;45:1360–1367
  20. Girard MT , Matsubara M , Fini ME . Transforming growth factor-β and interleukin-1 modulate metalloproteinase expression by corneal stromal cells . Invest Ophthalmol Vis Sci . 1991;32:2441–2454
  21. Niewderkorn JY , Peeler JS , Mellon J . Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea . Reg Immunolog . 1989;2:83–90
  22. Wilson SE , He YG , Weng J , et al.   Epithelial injury induces keratocyte apoptosis (hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing) . Exp Eye Res . 1996;62:325–338
  23. Dayer JM . The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis [review] . Rheumatology (Oxford) . 2003;42(suppl 2):ii3–ii10
  24. Nakamura Y , Sotozono C , Kinoshita S . Inflammatory cytokines in normal human tears . Curr Eye Res . 1998;17:673–676
  25. Solomon A , Dursun D , Liu Zuguo , et al.   Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease . Invest Ophthalmol Vis Sci . 2003;42:2283–2292
  26. Wilson WS , Duncan AJ , Jay JL . Effect of benzalkonium chloride on the stability of the precorneal film in rabbit and man . Br J Ophthalmol . 1975;59:667–669
  27. Broadway DC , Chang LP . Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva [review] . J Glaucoma . 2001;10:237–249
  28. Lavin MJ , Wormald RPL , Migdal CS , Hitchings RA . The influence of prior therapy on the success of trabeculectomy . Arch Ophthalmol . 1990;108:1543–1548

PII: S0002-9394(04)00997-3

doi: 10.1016/j.ajo.2004.08.028

American Journal of Ophthalmology
Volume 139, Issue 1 , Pages 72-77 , January 2005

Article Tools

* Image Usage & Resolution